Skip to main content
. 2019 Feb 22;39(2):BSR20182058. doi: 10.1042/BSR20182058

Figure 2. Trough concentration of CsA and serum creatinine level at each follow-up point after switching from tacrolimus to CsA were stable.

Figure 2